Background The obesity epidemic has major public health consequences. Expert dietetic and behavioural counselling with intensive follow-up is eff ective, but resource requirements severely restrict widespread implementation in primary care, where most patients are managed. We aimed to estimate the eff ectiveness and cost-eff ectiveness of an internet-based behavioural intervention (POWeR+) combined with brief practice nurse support in primary care.
Introduction
Obesity is a major threat to public health, 1 ,2 the prevalence has risen sharply since the early 1990s, 3 and most patients are managed in primary care. 4 Systematic reviews, 5 including that from the National Institute for Health and Care Excellence (NICE), 4 advocate dietary and physical activity intervention supported by intensive behavioural techniques. The low availability of high-level dietetic and behaviour-change expertise, and the little time available for counselling and follow-up, makes this approach challenging in the progressively resource-constrained primary care environment. A review 6 of randomised controlled trials in primary care (excluding trials with more than 30% attrition at 12 months, which is common in studies of obesity) showed little evidence of appropriately intensive behavioural counselling and suggested trained interventionists.
One alternative to a cadre of highly trained interventionists is to harness the capacity of the internet to help support behaviour change. Reviews suggest that automated interactive web-based interventions without human input can achieve greater weight loss than does no treatment or minimal interventions, but the evidence base included too many small, short-term trials in volunteer samples, arguing the need for large, pragmatic trials with at least 1 year of follow-up and including assessments of cost-eff ectiveness. 7, 8 The trials identifi ed by NICE mostly had expert lifestyle and behavioural input, and followed up patients intensively-on average 13 times per year during the fi rst 12 months. 4 NICE also estimated that any intervention costing £100 per kg lost was likely to be cost-eff ective if a 1 kg diff erence in weight was maintained for life. Automated interventions could be enhanced by human support, but although intensive support improves web-based weight management, 9 we are aware of no studies examining the eff ectiveness of brief support by primary care staff that is likely to be both more feasible and cost-eff ective. A 2015 review 10 identifi ed nine studies comparing internet support with minimal intervention, but two studies had unusual populations (university staff ; lactating women), and the only study to report fewer than ten contacts by behavioural counsellors documented less than 1·5 kg of weight loss and high attrition at 12 months, with only 49% of individuals followed up.
We did the POWeR+ trial to estimate the eff ectiveness and cost-eff ectiveness of a web-based behavioural weight management intervention (POWeR+) with either brief face-to-face nurse support or brief remote nurse support for obese patients managed in primary care.
Methods

Study design and patients
We did this pragmatic, parallel-group, randomised controlled trial at 56 primary care practices in central and nutrition.tw.physical activity.tw.exp exercise/*motor activity/*Physical Fitness. 23 (27·4%) studies were classifi ed as higher quality (quality and risk of bias), 57 (67·9%) studies were classifi ed as moderate quality, and nine (10·7%) studies were lower quality. Meta-analysis showed signifi cantly greater weight loss (kg) with e-Health interventions than with minimal interventions (mean diff erence −1·40, 95% CI −1·98 to −0·82; p<0·001). However, two studies had unusual populations (university staff ; lactating women), and the only study to report fewer than ten contacts by behavioural counsellors documented less than 1·5 kg weight loss and high attrition at 12 months, with only 49% of individuals followed up. Thus, evidence for the eff ectiveness of internet interventions using brief behavioural support in a primary care setting is poor.
Added value of this study
Our results show that clinically important weight reduction is possible with a web-based behavioural program lasting 6 months combined with brief remote follow-up. Patients assigned to the web-based intervention and either face-to-face nurse support (POWeR+Face-to-face) or remote nurse support (POWeR+Remote) achieved roughly 1·5 kg more weight loss than those assigned to the control group (evidence-based dietetic advice and 6 monthly nurse follow-up). Furthermore, 30% of patients in the POWeR+ groups maintained 5% weight loss by 12 months, with less recourse to other weight loss activities and with no increase in health service costs.
Implications of all the available evidence
The weight loss achieved with POWeR+ was similar to that achieved with the best performing interventions evaluated in a primary care setting over a 12 month period, including those produced by face-to-face commercial programmes. When combined with very brief staff support, the POWeR+ program could be feasibly used in most practices and could make a clinically important contribution to the management of obesity. Future research should assess the extent to which clinically important weight loss can be maintained beyond 1 year.
south England (around Southampton and Oxford). Up to 100 patients from each practice were randomly chosen, by use of computer-generated numbers, and invited to a screening appointment. Patients could also be referred opportunistically from routine practice appointments.
We enrolled individuals aged 18 years or older with a BMI of 30 kg/m² or more (or ≥28 kg/m² with hypertension, hypercholesterolaemia, or diabetes) as identifi ed from general practitioner (GP) routine electronic health records. We excluded patients with severe mental health problems (eg, psychosis; diffi culty completing outcomes), patients who were too ill to take part in a study such as this one or who were unable to change their diet (eg, individuals with severe heart, lung, kidney, bowel, or liver diseases), patients who were pregnant or breastfeeding, patients with a perceived inability to walk 100 m (physical activity diffi cult), and patients with another member of the household taking part or no regular access to the internet. The study was approved by the National Research Ethics Service Committee South Central-Southampton B (reference 11/SC/0455). All participants provided written informed consent.
Randomisation and masking
Patients were given details of how to log in and register to the POWeR+ intervention, whereupon individuals were presented with baseline questionnaires. Upon completion of the questionnaires, the website automatically randomly assigned patients (1:1:1), via computer-generated random numbers, to one of three intervention groups: evidencebased dietetic advice and 6 monthly nurse follow-up (control group); web-based intervention and face-to-face nurse support (POWeR+Face-to-face [POWeR+F] group); or web-based intervention and remote support (POWeR+Remote [POWeR+R group]). Participants and investigators were masked to group allocation at the point of randomisation; masking of participants was not possible after randomisation. The 12 month weight measurement was masked whenever possible.
Procedures
POWeR+ is a theory and evidence-based intervention to teach patients self-regulation and cognitive-behavioural techniques to form sustainable eating and physical activity habits for long-term weight management in a series of 24 web-based sessions designed to be used over 6 months, with novel content, links to external content, and email reminders. Patients initially chose either a low-calorie or a low-carbohydrate eating plan, but could change plans at any stage if they wished (appendix pp [1] [2] [3] [4] .
Participants assigned to the control group were directed to a set of two printable web-based pages with brief structured advice. This intervention was active, since it was intended to aid weight loss. The materials were developed by the Institute of Food Research to provide appealing strategies to minimise the pressure to cut down favourite foods, and to instead swap less healthy foods for healthier choices (healthy foods swap sheet), or to increase fruit and vegetable intake (we used the National Health Service [NHS] fi ve-a-day sheet). Our previous trial 11 documented 1·2 kg weight loss at 6 months when patients with hypertension received prompt sheets promoting healthy eating compared with a generic advice booklet. To enhance retention, participants were informed that this intervention had been shown to support weight loss. Nurses arranged brief follow-up (5-10 min appointments) with suffi cient time to measure weight at 6 months and 12 months, but not to provide explicit counselling.
The aim of the POWeR+F intervention was to provide automated behavioural counselling, with just three scheduled (and four optional) face-to-face nurse support sessions, thus requiring substantially less health professional skill and time than the evidence-based lifestyle interventions documented in the NICE review, 4 and hence being much easier to implement in the NHS. In addition to weight recording every 6 months, as in the control group, participants had three scheduled face-toface appointments in the fi rst 3 months, and then up to four more appointments during a further 3 months if needed (ie, 6 months in total). Weight gain on two consecutive logins triggered an automated email to the nurse advising that the patient needed further support, or patients could request additional support.
The aim of the POWeR+R intervention was to assess whether even briefer professional support for the web intervention could be eff ective. Patients could access the same web-based intervention as in the POWeR+F group. In addition to weight recording every 6 months, as in the control group, participants had three scheduled phone or email contacts and up to two optional phone or email contacts in the fi rst 6 months (triggered by weight gain or patient request, as in the POWeR+F group).
Outcomes
The primary outcome was weight loss averaged over 12 months. Weight loss was measured with participants lightly clothed without shoes, at the same time every day when possible, with automated digital scales (Tanita Europe BV, Amsterdam, the Netherlands). Piloting suggested that intensive follow-up for anything but the primary outcome would increase dropout, we therefore focused on weight. As such, the fi nal analysis plan (July 1, 2015), matching the clinical rationale for our original sample size, included a secondary analysis of weight-maintenance of 5% weight loss. This outcome is very important clinically, 12, 13 and facilitated direct comparison with a previous UK primary care trial 14 published after our study commenced. Although there was no explicit measurement of the work of participants (ie, how much time was spent doing the intervention activities), other secondary outcomes included health service resource use, use of the website (pages additional activities participants used to help lose weight. We also documented various other secondary outcomes (waist measurement, blood pressure, HbA 1c , liver function tests, self-reported measures of physical activity, and diet; appendix p 11). We planned to use Actiheart monitors in a randomised subset of individuals, but organising this method at a time of intensive fi nal follow-up became too diffi cult. Participants had appointments for weight measurement with the practice nurse at baseline and 6 months, and an appointment or home visit by a nurse researcher masked to group allocation at 12 months. When a blinded weight measurement could not be obtained, we used practice nurses' recorded weights, and when that was not possible, we used participants' reported weights. Participants received a £10 gift voucher with the 12 month appointment notifi cation letter as a thank you for participation, irrespective of whether an appointment was made. For self-reported measures, participants received three emails prompting online completion followed by a postal version of the questionnaire.
Statistical analysis
On Sept 25, 2013, the Trial Steering Committee advised an increase to the sample size to allow for clustering; this amendment required an extension to the planned recruitment period.
We allowed all groups to be compared with each other (α 0·05/3=0·017), but for the primary analysis compared each intervention group with the control group. For the primary outcome, we estimated that a standardised eff ect size of 0·33 (equivalent to 2-3 kg diff erence assuming a standard deviation of change of 6·5-7·5 kg 16, 17 ) , and 80% power, required 174 patients per group with complete data or 654 patients in total, allowing for a 20% loss to follow-up. After liaison with both the funder of the study and the Trial Steering Committee, the power calculation was revised on Sept 25, 2013, to allow for modest clustering at practice level if signifi cant clustering was recorded. We assumed recruitment of 18 patients per practice to achieve 15 patients at follow-up, of whom roughly fi ve to six patients would be in each of the two intervention groups at follow-up. Assuming fi ve patients per group in each practice for an intracluster correlation of 0·05-ie, a design eff ect of 1·2 (1 + [(5-1) × 0·05])-resulted in a minimum of 654 × 1·2=785 patients.
To avoid loss of data, on July 1, 2015, repeated measures ANOVA for the principal continuous outcome (ie, weight) was changed to mixed multivariate regression models to enable data to be used from any participant who had 6 months' or 12 months' data. We modelled the risk ratios compared with the control group for the number of patients achieving 5% weight loss. All regression models controlled for weight at baseline, sex, age, smoking, diabetes, medications (including orlistat used at baseline), any comorbidities, deprivation (Index of Material Deprivation 2010), and any clustering by practice. No interim analyses were undertaken.
Intention-to-treat analysis used both measured and reported weights in a multiply imputed dataset (based on Figure: Trial profi le *Reasons for withdrawal: the patient's situation changed (eg, pregnancy, moved house; n=18), the patient disliked their group (n=8), the patient had no time to participate or changed their mind (n=4), or no reasons were given (n=21).
replications)
. Secondary analyses used both complete cases and measured weights. We explored whether there was signifi cant eff ect modifi cation in subgroups using interaction terms in the models. Key pre-identifi ed subgroups were baseline waist measurement (high or very high waist vs low waist; men: high 94 cm, very high 102 cm; women: high 80 cm, very high 88 cm), and presence of metabolic syndrome (syndrome vs no syndrome). Metabolic syndrome 18 was defi ned as the presence of three out of fi ve conditions: elevated waist circumference (>94 cm for men, 80 cm for women), triglyceride concentrations of 1·7 mmol/L or more, reduced HDL-cholesterol (<1·00 mmol/L in men, <1·3 mmol/L in women), raised blood pressure (systolic >130 mm Hg or diastolic >85 mm Hg, or treatment of high blood pressure), and elevated fasting glucose (≥5·6 mmol/L). 18 We also explored outcomes according to the type of diet chosen by patients.
We obtained data for health service resource use from case-note review of medication, primary care visits, outpatient consultant, obesity-related admissions to accident and emergency and hospital (eg, for management of obesity and disorders aff ected by obesity, such as cardiovascular disease, control of asthma, and musculoskeletal problems [hip, back, and knee]; appendix pp 5-8). For the cost-eff ectiveness analysis, we measured outcomes as incremental costs per kg weight loss; we imputed missing data and used bootstrapping methods to produce confi dence intervals. We did analysis with Stata (version 14).
Role of the funding source
The funder of the study had no role in study design, data collection, data interpretation, data analysis, or writing of the report. The corresponding author had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication. Figure 1 shows the trial profi le. Between Jan 30, 2013, and March 20, 2014, 826 patients underwent randomisation. After exclusion of eight participants identifi ed as ineligible post-randomisation, 818 individuals were randomly assigned to the control group (n=279), the POWeR+F group (n=269), or the POWeR+R (n=270). 439 (54%) patients had a weight recorded at 6 months' follow-up and 666 (81%) patients had a weight recorded at 12 months. 510 (77%) of the 666 recordings were blinded, 28 (4%) were unblinded, and 128 (19%) were self-reported. The number of self-reported measurements was similar between groups (control n=40, POWeR+F n=48, POWeR+R n=40). Baseline characteristics were generally well balanced (table 1). The practice intracluster correlation for weight in the repeated measures analysis was 0·01 (95% CI 0·003-0·09) when controlling for baseline weight.
Results
Of the 539 participants randomised to the POWeR+ intervention groups, 524 (97%) participants started the fi rst session and 404 (75%) participants completed all three core sessions (n=208 in the POWeR+F group and n=196 in the POWeR+R group). Participants completed a mean of 10·97 (SD 12·65) weight and goal reviews (range zero to 52), with a mean of 10·16 (11·92) completed reviews in the POWeR+F group and 11·85 (13·38) in the POWeR+R group. The median number of nurse contacts was four (range zero to seven) in both intervention groups, with a median of two (IQR one to three) face-to-face contacts, one (zero to two) phone contact, and one (zero to two) email contact in the POWeR+F group, and a median of one (zero to two) phone contact and three (two to four) email contacts in the POWeR+R group. We recorded a 2-2·5 kg diff erence in weight reduction for participants who completed more than the fi rst basic stage of the program.
Patients in the control group maintained a weight loss of almost 3 kg in total over 12 months (table 2) . The primary imputed analysis showed that compared with the control group, patients in the POWeR+F group achieved an estimated additional 1·5 kg reduction averaged over 12 months and patients in the POWeR+R group achieved an additional 1·3 kg reduction (table 3) . A secondary analysis of only the complete cases showed a greater weight reduction at 12 months in the intervention groups than in the control group (POWeR+F: -1·78 kg, 95% CI -2·81 to -0·76; p=0·001; POWeR+R: -1·6 kg, -2·6 to -0·6; p=0·002; appendix pp 9, 10).
By month 12, with data for complete cases, the proportion of patients maintaining a 5% reduction in weight or more Data are mean (SD), n (%), or n/N (%), unless otherwise specifi ed. Data were missing for some individuals. IMD=Index of Material Deprivation. was 19% in the control group, 28% in the POWeR+F group, and 32% in the POWeR+R group; the imputed estimates were 21%, 29%, and 32%, respectively (table 4) . We reviewed 753 case notes from the GP electronic health records for 12 months after recruitment. Mean intervention costs were low both per person using the services (£22 [95% CI [21] [22] [23] for POWeR+F and £12 [11] [12] [13] for POWeR+R) and for all participants in each group (£17 [15] [16] [17] [18] and £9 [8] [9] [10] , respectively). Addition of the estimated cost of the website raised the overall costs for all participants to £18 [95% CI [16] [17] [18] [19] in the POWeR+F group and £10 [9] [10] [11] in the POWeR+R group. We recorded greater diff erences in overall costs for estimated overall NHS resource use related to obesity in the intervention versus the control groups (appendix pp 7, 8) . Bootstrapping analysis showed that diff erences in costs compared with the control group were £23 for POWeR+F and -£36 for POWeR+R; neither of these diff erences was statistically signifi cant (table 5). The estimated incremental overall NHS cost per kg weight loss was £18 for POWeR+F and -£25 for POWeR+R (table 5)-ie, POWeR+R was more eff ective and cost less than the control strategy. The probability of cost-eff ectiveness was more than 80% in cost-eff ectiveness acceptability curves for both POWeR+F and POWeR+R versus control (88% and 98%, respectively; appendix pp 8, 9).
For patients returning the fi nal questionnaire, almost half the people in the control group were doing additional activities, compared with almost two-fi fths in the POWeR+F group and only a quarter in the POWeR+R group (table 6) . Participants in the intervention groups also felt more enabled to manage their weight problem than did those in the control group (table 6) .
Due to the priority to obtain follow-up data for weight, and the clear feedback from piloting suggesting that pressurising participants to have blood taken was offputting, achievement of high follow-up for blood samples was necessarily a secondary priority; therefore, only a small number of participants had follow-up blood measurements. The available results suggest generally positive directions of outcomes in the POWeR+ groups versus the control group, although changes were mostly non-signifi cant (raised HDL cholesterol, lower aspartate transaminase and alanine transaminase, lower HbA 1C ; appendix pp [12] [13] [14] . The low completion rate of the EuroQol-5D (EQ-5D) questionnaire reduces the reliability of these data; as such, the direction of change in EQ-5D scores is diffi cult to interpret, particularly because the estimate of direction of change varies dependent on whether we controlled for baseline values (appendix p 18).
Body fat percentage and blood pressure were recorded in most participants at follow-up (n=454 and n=494, respectively), and although there were no consistent changes in blood pressure in any of the three groups, fat mass was slightly reduced at 12 months in both POWeR+ groups (appendix p 15).
In subgroup analysis, we recorded some evidence of a reduced eff ect of the POWeR+F group at 6 months in patients with metabolic syndrome, but no signifi cant eff ect of type of diet chosen (appendix p 9). No harms were reported during the study
Discussion
This study is one of few to compare simple weight management interventions using primary care staff for support to manage obesity. Clinically important weight loss (5% reduction) was achieved by some participants in the control group, and the crude mean weight reduction by 12 months was not signifi cantly lower in the POWeR+ behavioural web-based intervention groups. However, in the POWeR+ groups, signifi cantly more weight loss occurred over 12 months, and more participants maintained clinically important weight reduction and felt enabled to manage their weight. This outcome was achieved with no increase in health service costs despite brief nurse remote support.
Individuals who take part in trials are likely to be fairly well motivated, but participants are also the intended target group in whom intervention is likely to be most helpful. The present study was large and pragmatic,
Complete cases
Imputed data ≥5% reduction in weight Risk ratio versus control ≥5% reduction in weight Risk ratio versus control mimicking the everyday conditions in primary care settings; therefore, patients in the control group were not closely regulated and so undertook other activities to lose weight. However, this factor is also a strength because resulting estimates are more refl ective of real-world practice. Participants with obesity in primary care settings are notoriously diffi cult to follow up, but we achieved follow-up of more than 80% of individuals at 12 months. Loss to follow-up was similar between groups, which reduces the eff ect of missing data. Furthermore, we imputed data for the primary analysis, thus providing more conservative estimates of eff ectiveness than complete cases. However, in practice, multiple imputation modifi ed the estimates only slightly, which suggests that attrition bias was not a major issue. On the basis of the experience of piloting, whereby pressure to achieve follow-up of both primary and secondary outcomes resulted in participants dropping out, our eff orts were concentrated on maximising the primary outcome, which resulted in fewer secondary outcomes being available. As a result, even though estimates used multiple imputation, the results for blood samples should be interpreted cautiously. Nevertheless, we recorded signifi cant weight loss irrespective of the method of specifying the weight outcome (average reduction over 12 months as specifi ed in the funding application, or clinically important [5%] weight loss at 6 months or 12 months), and most secondary outcomes also changed in positive directions, albeit mostly not signifi cantly, suggesting that selective reporting and type I error are less likely.
In the control group, we observed 3% loss in weight, and 12% and 19% of participants in this group maintained a clinically important weight loss (5%) at 6 and 12 months, respectively. These results are consistent with our previous fi ndings, 11 showing that a brief intervention promoting the use of simple sheets for food swaps and fi ve-a-day fruit and vegetable consumption aids weight control. Some of the eff ective weight management in this group might also be due to the motivational eff ects of regular follow-up weighing by the nurse, and to the undertaking of additional activities to help themselves (which about half of participants did). By contrast, fewer individuals off ered the POWeR+ interventions undertook other activities, and they felt signifi cantly more enabled to manage their weight.
Systematic reviews 4, 6, 19 of interventions in other settings and primary care suggest that both intensive dietetic behavioural counselling and intensive follow-up are usually necessary to achieve eff ective weight reduction. However, we found that a behavioural web-based intervention such as POWeR+ was eff ective with just a few brief phone calls and emails, plus weight monitoring every 6 months. The weight loss achieved with POWeR+ compares favourably with other internet-based interventions, which, on average (albeit with high heterogeneity), have led to only short-term weight loss, of less than 1 kg weight loss compared with no treatment, or less than 2 kg when combined with face-to-face support, based on a review of predominantly motivated volunteer samples. 20 Improved weight loss (around 5 kg) with an internet-based program has only been achieved with much more intensive human support (eg, weekly 20 min contact for 12 weeks, and then monthly up to 24 month follow-up 9 ). Encouragingly, the weight loss achieved with POWeR+ was similar to that achieved with the bestperforming interventions 21 evaluated over 12 months in a primary care setting, including those produced by face-toface commercial programmes.
The estimates of resource use suggest that neither intervention was resource intensive. Considering overall NHS costs, fewer NHS resources were used in the POWeR+R group, mainly due to reduced primary care costs. In view of the variability of cost estimates, these results should be treated with some caution, but health service costs are unlikely to be signifi cantly increased with the remote POWeR+ intervention. We also recorded that POWeR+ users felt signifi cantly more enabled to manage their condition, so if individuals can be enabled to manage their own condition without needing signifi cant face-toface contact, this could empower self-management more generally. Previous modelling by NICE showed that at least a 1 kg per head weight loss among overweight or obese adults is likely to be cost-eff ective, provided that the cost per person of intervening is less than £100 and the weight diff erence is maintained for life. The present results suggests that irrespective of whether intervention costs or overall costs are used, both POWeR+ interventions achieve weight losses at a cost per kg that is less that required by NICE. 4 The POWeR+ intervention was for 6 months, but the number of patients maintaining clinically important weight loss remained steady up to 1 year, which suggests that long-term benefi t could be achieved. However, future research should assess the extent to which clinically important weight loss can be maintained beyond 1 year.
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